Half-Year Results and Business UpdatePositive Phase I data with TG4050 in operable Head and Neck Squamous Cell Carcinoma (HNSCC) 100% ...

Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults ...

Lumina AI is proud to announce that Ben Martin and Sam Martin, co-inventors of RCL with Dr. Morten Middelfart, are rejoining the company as AI Research Scientists to support its next phase of growth.

Peer review and the editorial process yield frequent improvements in research abstracts of randomized clinical trial (RCT) ...

Stochastic dynamical systems arise in many scientific fields, such as asset prices in financial markets, neural activity in ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Dr. Allison Winter secured a VeloSano grant after five years of rejected proposals for central nervous system lymphoma ...

Dr. Vince Clinical Research announces first dosing in atopic dermatitis patients with Enveda’s first-in-class investigational ...

Some feel the guidance may encourage consistent follow-up of overall survival after accelerated approvals, but others remain focused on speeding new drugs to patients.

Sacubitril/valsartan shows evidence of benefit in the first randomized trial evaluating a drug treatment for patients with ...

The Global Institute for Hispanic Health at Driscoll Children's Hospital aims to bring clinical research opportunities to ...